Brought to you by:
Maria Gifford
Peter Lawrence receives SVS Lifetime Achievement Award
A career that nearly began on the football field instead of in the operating room culminated at VAM 2026 in the highest honor of the Society for Vascular Surgery (SVS), as Peter Lawrence, MD, received the SVS Lifetime Achievement Award…
Can tailored thromboprophylaxis reduce amputation risk?
One in five endovascular procedures fails within six months and for decades vascular surgeons have answered that statistic with the same blunt toolkit: aspirin, clopidogrel, or whatever combination a given surgeon prefers. This year’s Frank J. Veith Distinguished Lecture at…
Elective PVI for claudication linked to worse limb outcomes and higher costs
Vascular surgeons have long debated whether and when to intervene on claudication. A new study suggests the field may be intervening too often, too early and with consequences that compound over time. The findings, recently published in the Journal of…
Data support conservative approach to claudication in elderly patients
Claudication rarely takes a limb. But in patients over 80, the attempt to treat it surgically may take something just as important. New data, presented at VAM 2026 by Jeffrey Siracuse, MD, makes the case that for octogenarians with intermittent…
TCAR demonstrates durable long-term outcomes with few reinterventions
Across more than 1,000 transcarotid artery revascularization (TCAR) procedures performed over eight years at a single high-volume institution, a recent study found only 12 patients required reintervention — a 1.1% rate that speaks to the durability of TCAR. The data…
Advances in medical management could redefine PAD care
“Peripheral arterial disease [PAD] should no longer be viewed simply as a problem of arterial obstruction requiring procedural intervention,” said Mohamed Zayed, MD, PhD, associate professor of Surgery and Radiology at Washington University School of Medicine. That assertion cuts to…
Deep vein arterialization challenges notion of ‘no-option’ CLTI
“Patients previously considered ‘no-option’ may no longer truly be without options,” said Anahita Dua, MD, associate professor at Harvard Medical School and a vascular surgeon at Massachusetts General Hospital. That assertion sums up the central finding of an analysis comparing…
DCB therapy reduces MALE rates across femoropopliteal lesion complexity
In an era of expanding device options and the clinical temptation to match procedural complexity to lesion complexity, a new study offers a counterintuitive but data-driven argument: In femoropopliteal disease, doing less may actually deliver more. Research using the Vascular…
Pre-operative guideline adherence tied to fewer major adverse limb events
For patients with claudication, surgical revascularization is meant to restore quality of life. But a new retrospective study finds that most patients are arriving for that intervention without completing the pre-operative care that guidelines recommend and that the shortfall carries…
Tibial access in claudicants linked to guideline-discordant care and CLTI progression
Retrograde tibial access has long offered technical advantages in peripheral vascular procedures, but a new study raises concern that its use in patients with claudication may be driving treatment decisions that exceed what current guidelines recommend, creating a clinically significant…